We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 20.18%
2 Consumer Discretionary 14.97%
3 Financials 14.24%
4 Technology 12.89%
5 Industrials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WOOF
1476
DELISTED
VCA Inc.
WOOF
$2.48M ﹤0.01%
36,678
+3,272
+10% +$208K
CPN
1477
DELISTED
Calpine Corporation
CPN
$2.43M ﹤0.01%
164,796
+31,540
+24% +$467K
NNN icon
1478
NNN REIT
NNN
$8.9B
$2.42M ﹤0.01%
46,852
+119
+0.3% +$5.52K
HII icon
1479
Huntington Ingalls Industries
HII
$12.8B
$2.42M ﹤0.01%
14,371
+16
+0.1% +$2.43K
CSC
1480
DELISTED
Computer Sciences
CSC
$2.37M ﹤0.01%
47,718
+35
+0.1% +$1.42K
HMHC
1481
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$2.36M ﹤0.01%
150,987
+17,487
+13% +$318K
GLPI icon
1482
Gaming and Leisure Properties
GLPI
$12.7B
$2.36M ﹤0.01%
68,341
+21,583
+46% +$716K
TD icon
1483
Toronto Dominion Bank
TD
$205B
$2.33M ﹤0.01%
54,661
-2,356,525
-98% -$103M
CSL icon
1484
Carlisle Companies
CSL
$14.8B
$2.33M ﹤0.01%
22,078
+157
+0.7% +$15.9K
AVT icon
1485
Avnet
AVT
$7.89B
$2.29M ﹤0.01%
56,592
+5,801
+11% +$242K
SVC
1486
Service Properties Trust
SVC
$1.06B
$2.27M ﹤0.01%
15,793
+3,469
+28% +$457K
RGA icon
1487
Reinsurance Group of America
RGA
$16.3B
$2.25M ﹤0.01%
23,166
+9
+0% +$863
DINO icon
1488
HF Sinclair
DINO
$16.3B
$2.23M ﹤0.01%
94,018
+13,772
+17% +$410K
CCK icon
1489
Crown Holdings
CCK
$12.8B
$2.23M ﹤0.01%
43,919
+4,713
+12% +$246K
NBR icon
1490
Nabors Industries
NBR
$1.38B
$2.19M ﹤0.01%
4,366
+111
+3% +$52.5K
WPC icon
1491
W.P. Carey
WPC
$16.3B
$2.19M ﹤0.01%
32,176
-1,583
-5% -$99.4K
WFT
1492
DELISTED
Weatherford International plc
WFT
$2.17M ﹤0.01%
391,919
+46,794
+14% +$305K
CRD.B icon
1493
Crawford & Co Class B
CRD.B
$583M
$2.17M ﹤0.01%
256,065
+3,937
+2% +$28.7K
BRCD
1494
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$2.16M ﹤0.01%
235,545
+34,956
+17% +$313K
CBT icon
1495
Cabot Corp
CBT
$4.47B
$2.16M ﹤0.01%
47,307
+180
+0.4% +$8.38K
WPRT
1496
Westport Fuel Systems
WPRT
$33.2M
$2.15M ﹤0.01%
+128,919
New +$2.78M
RJF icon
1497
Raymond James Financial
RJF
$34.7B
$2.15M ﹤0.01%
65,445
+11,044
+20% +$378K
RGLD icon
1498
Royal Gold
RGLD
$19.6B
$2.15M ﹤0.01%
29,858
-1,787
-6% -$106K
OHI icon
1499
Omega Healthcare
OHI
$13.9B
$2.13M ﹤0.01%
62,861
+23,320
+59% +$778K
DFRG
1500
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$2.13M ﹤0.01%
148,374
+4,174
+3% +$65K

Similar funds

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.